Natural Products
| Catalog No. | Information |
| CFN95157 | Formononetin-8-C-beta-D-apiofuranosyl-(1->6)-O-beta-D-glucopyranoside Reference standards. |
| CFN95156 | Pueroside C Reference standards. |
| CFN95151 | Quercetin 3-Caffeylrobinobioside Reference standards. |
| CFN95155 | Puerol B (+/-)-Puerol B shows inhibitory activity on AGEs formation in vitro. |
| CFN95154 | 3-O-[5'''-O-feruloyl-beta-D-apiofuranosyl(1'''->2'')-beta-D-glucopyranosyl] rhamnocitrin Reference standards. |
| CFN95153 | Patulitrin Patulitrin has antioxidant, anti-inflammatory, and larvicidal activities, oral and topical administration of patuletin and patulitrin inhibited acute inflammation in mice. |
| CFN95152 | New Compound 1 Reference standards. |
| CFN95150 | 3,7,25-Trihydroxycucurbita-5,23-dien-19-al Reference standards. |
| CFN95149 | Silybin A Silybin A has oxidative effects, it shows stronger effects on cell growth inhibition and apoptosis induction than silybin. |
| CFN95148 | Ampelopsin G Reference standards. |
| CFN95147 | Leachianol F Reference standards. |
| CFN95146 | Leachianol G Reference standards. |
| CFN91116 | 5,7,3',4'-Tetramethoxyflavone 5,7,3',4'-Tetramethoxyflavone (TMF) possesses various bioactivities, including antifungal, antimalarial, antimycobacterial, and anti-inflammatory activities; it also exhibits chondroprotective activity by targeting β-catenin signaling in vivo and in vitro. TMF protects chondrocytes from ER stress-induced apoptosis through regulation of the IRE1α pathway.TMF inhibits the expression of tyrosinase, tyrosine-related protein (TRP)-1, and TRP-2 mRNA, which could be the mechanism of its melanogenesis inhibitory activity. |
| CFN95145 | Rhamnocitrin 3-apiosyl-(1->2)-glucoside Reference standards. |
| CFN95144 | Complanatoside C Reference standards. |
| CFN95143 | Dehydrojuncusol Dehydrojuncusol, a new inhibitor of hepatitis C virus RNA replication, it inhibits infection of different HCV genotypes by targeting the NS5A protein and is active against resistant HCV variants frequently found in patients with treatment failure. |
| CFN95142 | Daidzein-4'-glucoside Reference standards. |
| CFN95141 | Pueroside B Pueroside B may can treat coronary heart disease, it can interact with two or more targets[peroxisome proliferator activated receptor γ (PPAR-γ), angiotensin-converting enzyme (ACE), hydroxymethylglutaryl coenzyme A receptor (HMGR), cyclooxygenase-2 (COX2), and thrombin]. |
| CFN95140 | 7-(4-Hydroxyphenyl)-1-phenyl-4-hepten-3-one 7-(4-Hydroxyphenyl)-1-phenyl-4-hepten-3-one as a beneficial compound to ameliorate the deleterious effects of Aβ on dendrite integrity and cell survival, and may provide new insights on drug discovery of Alzheimer's disease (AD). |
| CFN95139 | 7-(4-hydroxy-3-methoxyphenyl)-1-phenylhept-4-en-3-one (DPHB) Reference standards. |
| CFN95137 | 5-Hydroxy-1-(4-hydroxyphenyl)-7-phenyl-3-heptanone (AO 2210) (±)-5-hydroxyl-1-(4′-hydroxyphenyl)-7-phenyl-3-heptanone have digestibility inhibition in vitro in cow rumen fluid. |
| CFN95136 | Orientalide Reference standards. |
| CFN95135 | 5-Hydroxy-7-(4'-hydroxy-3'-methoxyphenyl)-1-phenyl-3-heptanone (DHPA) 5-Hydroxy-7-(4'-hydroxy-3'-methoxyphenyl)-1-phenyl-3-heptanone (DHPA) is a pancreatic lipase inhibitor, it shows antihyperlipidemic activity. |
| CFN95134 | Rhamnocitrin 3-glucoside Reference standards. |
| CFN95133 | Gardenin D Gardenin D has antioxidant, and antiproliferative activities. |
| CFN91105 | 3beta-Methoxy-2,3-dihydrowithaferin A 3beta-Methoxy-2,3-dihydrowithaferin A has cytoprotective activity, it protects normal cells against stress. |
| CFN91095 | Gardoside Reference standards. |
| CFN95132 | Emodin-8-O-beta-gentiobioside Reference standards. |
| CFN95131 | Torosachrysone 8-O-beta-gentiobioside Reference standards. |
| CFN95130 | Cassiaglycoside II Reference standards. |
| CFN91094 | 6-Hydroxyluteolin 7-glucoside Reference standards. |
| CFN91093 | Neoastilbin Neoastilbin may have antioxidant and anti-inflammatory activities, it shows potent inhibition of lens aldose reductase. |
| CFN91088 | Bacoside A3 Bacoside A3 has antioxidant potential, it shows comparatively higher neuroprotective response analysed as higher cell viability and decreased intracellular ROS. Bacoside A3 shows a newer potential role in the clinical management of opioid withdrawal induced depression. Bacoside A3 inhibited both basal activity as well as verapamil-stimulated ATPase activity, thus its affinity towards P-gp; the interaction of bacosides (A3/A) with Tryptophan hydroxylase (TPH) might up-regulate its activity to elevate the biosynthesis of 5-HT, thereby enhances learning and memory formation. |
| CFN91082 | Bacopaside X Bacopaside X (9.06 μM) showed binding affinity towards the D1 receptor. |
| CFN91079 | Sterebin E Sterebin E may have anti-inflammatory activity. |
| CFN91078 | Sterebin A Sterebin A may have anti-inflammatory activity. |
| CFN95129 | 1-Phenyl-2-propanol Reference standards. |
| CFN95128 | Yuankanin Reference standards. |
| CFN95127 | Yuanhuanin Reference standards. |
| CFN95126 | Maculosidin Maculosidine affect the PS I electron acceptors on leaf discs, it can inhibit ATP synthesis, basal, phosphorylating and uncoupled electron transport acting as Hill reaction inhibitors on spinach chloroplasts. |
| CFN95125 | Microgrewiapine A Microgrewiapine A is a selective cytotoxic agent for colon cancer cells over normal colon cells and to exhibit nicotinic receptor antagonistic activity for both the hα3β4 and hα4β2 receptor subtypes. |
| CFN95124 | Asiaticoside B Asiaticoside B has notable cytotoxicity against HepG2 and MCF-7 cancer cell lines. |
| CFN95123 | 3'-Angeloyloxy-4'-senecioyloxy-2',3'-dihydrooroselol Reference standards. |
| CFN95121 | Cistantubuloside C1 Reference standards. |
| CFN95120 | Cassiaside C Reference standards. |
| CFN95119 | Isorubrofusarin 10-gentiobioside Isorubrofusarin 10-gentiobioside shows promising inhibitory activity against AChE/BACE1. |
| CFN95118 | Polygalin C Reference standards. |
| CFN91072 | 19 alpha-Hydroxyasiatic acid 19 alpha-Hydroxyasiatic acid shows significant anticoagulant effect on the extrinsic pathway. |
| CFN91071 | Isosilybin B Isosilybin B causes androgen receptor degradation in human prostate carcinoma cells via PI3K-Akt-Mdm2-mediated pathway, it has anti-prostate cancer (PCA) activity that is mediated via cell cycle arrest and apoptosis induction. Isosilybin B showed inhibitory effect on CYP2C8 activity. It inhibited both monophenolase (IC50 = 1.7-7.6 μM) and diphenolase (IC50 = 12.1-44.9 μM) of tyrosinase. |
| CFN91070 | Isosilybin A Isosilybin A is a partial PPARγ agonist, it significantly induced ABCA1 protein expression, it inhibited both monophenolase (IC50 = 1.7-7.6 µM) and diphenolase (IC50 = 12.1-44.9 µM) of tyrosinase. Isosilybin A shows anti-angiogenic efficacy, it has anti-prostate cancer (PCA) activity that is mediated via cell cycle arrest and apoptosis induction. |
